The 2011 Leading Animal Health Companies R&D Expenditures and Major Programs

January 2010 | 75 pages | ID: L98619E3B92EN
Venture Planning Group

Abstracts

Global PDF: US$ 3,700.00

Each company analysis provides:

• Estimated R&D budget.
• Research facilities and staff.
• New technologies, products and applications in R&D, including their development phase and introduction dates.

The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly, Fort Dodge/Wyeth, Merial, Novartis, Pfizer, Schering-Plough and Virbac.

Contains 75 pages